Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a
The outbreak of the new coronavirus disease 2019 (COVID-19) has spread rapidly worldwide. Until now, no definite effective treatment has been identified. We reported 3 patients with severe COVID-19 treated with pegylated interferon alfa 2a with satisfactory recovery. Based on these observations, ran...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | IDCases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214250920301451 |
id |
doaj-ba530b11c12e41e2828cb01c42c810b1 |
---|---|
record_format |
Article |
spelling |
doaj-ba530b11c12e41e2828cb01c42c810b12021-07-02T19:46:19ZengElsevierIDCases2214-25092020-01-0121e00837Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2aRania M. El-Lababidi0Mohamad Mooty1Maria-Fernanda Bonilla2Nouran M. Salem3Department of Pharmacy Services, Cleveland Clinic Abu Dhabi, Al Maryah Island, p.o. box 112412, Abu Dhabi, United Arab Emirates; Corresponding author.Department of Infectious Diseases, Medical Subspecialties Institute, Cleveland Clinic Abu Dhabi, Al Maryah Island, Abu Dhabi, p.o. box 112412, United Arab EmiratesDepartment of Infectious Diseases, Medical Subspecialties Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab EmiratesDepartment of Pharmacy Services, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab EmiratesThe outbreak of the new coronavirus disease 2019 (COVID-19) has spread rapidly worldwide. Until now, no definite effective treatment has been identified. We reported 3 patients with severe COVID-19 treated with pegylated interferon alfa 2a with satisfactory recovery. Based on these observations, randomized studies with interferons should be considered in deteriorating patients infected with COVID-19.http://www.sciencedirect.com/science/article/pii/S2214250920301451Coronavirus disease 2019Pegylated interferon alfa 2aInterferonsSARS-CoV-2 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Rania M. El-Lababidi Mohamad Mooty Maria-Fernanda Bonilla Nouran M. Salem |
spellingShingle |
Rania M. El-Lababidi Mohamad Mooty Maria-Fernanda Bonilla Nouran M. Salem Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a IDCases Coronavirus disease 2019 Pegylated interferon alfa 2a Interferons SARS-CoV-2 |
author_facet |
Rania M. El-Lababidi Mohamad Mooty Maria-Fernanda Bonilla Nouran M. Salem |
author_sort |
Rania M. El-Lababidi |
title |
Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a |
title_short |
Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a |
title_full |
Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a |
title_fullStr |
Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a |
title_full_unstemmed |
Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a |
title_sort |
treatment of severe pneumonia due to covid-19 with peginterferon alfa 2a |
publisher |
Elsevier |
series |
IDCases |
issn |
2214-2509 |
publishDate |
2020-01-01 |
description |
The outbreak of the new coronavirus disease 2019 (COVID-19) has spread rapidly worldwide. Until now, no definite effective treatment has been identified. We reported 3 patients with severe COVID-19 treated with pegylated interferon alfa 2a with satisfactory recovery. Based on these observations, randomized studies with interferons should be considered in deteriorating patients infected with COVID-19. |
topic |
Coronavirus disease 2019 Pegylated interferon alfa 2a Interferons SARS-CoV-2 |
url |
http://www.sciencedirect.com/science/article/pii/S2214250920301451 |
work_keys_str_mv |
AT raniamellababidi treatmentofseverepneumoniaduetocovid19withpeginterferonalfa2a AT mohamadmooty treatmentofseverepneumoniaduetocovid19withpeginterferonalfa2a AT mariafernandabonilla treatmentofseverepneumoniaduetocovid19withpeginterferonalfa2a AT nouranmsalem treatmentofseverepneumoniaduetocovid19withpeginterferonalfa2a |
_version_ |
1721323606720380928 |